Value investing message boards image Log on |  Join ($$) Stock market forums image VF "How To" Guide        Welcome, guest! Learn about guest access                       
ValueForum.com Home
• Related Discussion Forum Messages
As a ValueForum member, this section would contain PLSE message board posts where the ticker symbol PLSE has been mentioned by ValueForum members in posts. Learn more about guest access, and benefits of membership -- we hope you will consider joining ValueForum or trying out our service with a 24 hour trial pass.

• Latest PLSE SEC Filings

Filings Format Description Filing Date File/Film Number
4  Documents Statement of changes in beneficial ownership of securities
Acc-no: 0001209191-17-065914 Size: 5 KB
2017-12-15
4  Documents Statement of changes in beneficial ownership of securities
Acc-no: 0001209191-17-065527 Size: 5 KB
2017-12-13
4  Documents Statement of changes in beneficial ownership of securities
Acc-no: 0001209191-17-065525 Size: 7 KB
2017-12-13
S-8  Documents Securities to be offered to employees in employee benefit plans
Acc-no: 0001625101-17-000046 (33 Act)  Size: 148 KB
2017-11-28 333-221788
171226103
8-K  Documents Current report, items 5.02 and 9.01
Acc-no: 0001625101-17-000044 (34 Act)  Size: 337 KB
2017-11-28 001-37744
171225583
10-Q  Documents   Interactive Data Quarterly report [Sections 13 or 15(d)]
Acc-no: 0001625101-17-000042 (34 Act)  Size: 4 MB
2017-11-08 001-37744
171186908
8-K/A  Documents [Amend] Current report, item 5.02
Acc-no: 0001625101-17-000040 (34 Act)  Size: 40 KB
2017-11-08 001-37744
171185910
8-K  Documents Current report, items 2.02 and 9.01
Acc-no: 0001625101-17-000038 (34 Act)  Size: 250 KB
2017-11-07 001-37744
171183759
4  Documents Statement of changes in beneficial ownership of securities
Acc-no: 0001209191-17-059432 Size: 5 KB
2017-11-06
4  Documents Statement of changes in beneficial ownership of securities
Acc-no: 0001209191-17-059429 Size: 5 KB
2017-11-06
More PLSE SEC Filings


Related news from
Sat, 16 Dec 2017
01:32:00 +0000
Pulse Biosciences Grants Equity Inducement Awards to New Employees
Pulse Biosciences, Inc. , a medical technology company developing a proprietary therapeutic tissue treatment based on its Nano-Pulse Stimulation platform, today announced that the Compensation Committee of the company’s Board of Directors granted non-qualified stock options to purchase an aggregate of 121,000 shares of Pulse Biosciences common stock to seven new employees under Pulse Biosciences, Inc....
Thu, 14 Dec 2017
13:05:11 +0000
Does Pulse Biosciences Inc’s (NASDAQ:PLSE) CEO Pay Reflect Performance?
Darrin Uecker has been at the helm as CEO of Pulse Biosciences Inc (NASDAQ:PLSE), which has grown to a market capitalization of USD$391.86M. Recognizing whether CEO incentives are aligned withRead More...
Mon, 04 Dec 2017
13:05:00 +0000
New Research: Key Drivers of Growth for Synchrony Financial, Pulse Biosciences, Ally Financial, RealPage, Briggs & Stratton, and Genesis Energy — Factors of Influence, Major Initiatives and Sustained Production
NEW YORK, Dec. 04, 2017-- In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors, traders, and shareholders of Synchrony ...
Tue, 07 Nov 2017
21:22:00 +0000
Pulse Biosciences Quarterly Investor Conference Call
Pulse Biosciences, Inc. , a medical technology company developing a proprietary therapeutic tissue treatment based on its Nano-Pulse Stimulation platform, today reports recent corporate developments and financial results for the quarter ended September 30, 2017.
Tue, 07 Nov 2017
15:00:00 +0000
Pulse Biosciences, Inc. to Host Earnings Call
NEW YORK, NY / ACCESSWIRE / November 7, 2017 / Pulse Biosciences, Inc. (NASDAQ: PLSE ) will be discussing their earnings results in their Q3 Earnings Call to be held on November 7, 2017 at 4:30 PM Eastern ...
Mon, 06 Nov 2017
12:10:00 +0000
Corporate News Blog - Medical Technology Company Pulse Biosciences Announces Changes to its Board
Research Desk Line-up: C. R. Bard Post Earnings Coverage LONDON, UK / ACCESSWIRE / November 6, 2017 / Pro-Trader Daily takes a look at the latest corporate events and news making the headlines for Pulse ...
Fri, 03 Nov 2017
12:00:00 +0000
Pulse Biosciences Announces Transition of Board of Directors, Extends Appreciation to Retiring Members and Welcomes New Board Members
Pulse Biosciences, Inc. , a medical technology company developing proprietary therapeutic tissue treatments based on its Nano Pulse Stimulation platform, today announced changes to the composition of its Board of Directors.
Fri, 03 Nov 2017
11:50:00 +0000
Detailed Research: Economic Perspectives on Discover Financial, Pulse Biosciences, The Travelers Companies, Xylem, Cheniere Energy Partners, and Cheniere Energy – What Drives Growth in Today's Competitive Landscape
NEW YORK, Nov. 03, 2017-- In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors, traders, and shareholders of Discover ...
Tue, 24 Oct 2017
21:00:00 +0000
Pulse Biosciences to Host Quarterly Investor Conference Call on November 7, 2017
Pulse Biosciences, Inc., a medical technology company developing a proprietary therapeutic tissue treatment based on its Nano-Pulse Stimulation platform, today announced it will host its quarterly investor conference call on Tuesday, November 7, 2017 at 1:30 p.m.
Sun, 15 Oct 2017
17:37:15 +0000
Healthcare Industry Trends And Its Impact On Pulse Biosciences Inc (PLSE)
Pulse Biosciences Inc (NASDAQ:PLSE), a USD$399.35M small-cap, operates in the healthcare industry, which has experienced tailwinds from issues such as higher demand driven by an aging population and the increasingRead More...
Mon, 25 Sep 2017
12:00:00 +0000
Pulse Biosciences Announces $30 Million Private Placement
Pulse Biosciences, Inc. , a medical technology company developing a proprietary therapeutic tissue treatment based on its Nano-Pulse Stimulation platform, today announced that it has entered into a stock purchase agreement with Robert W.
Mon, 11 Sep 2017
19:37:00 +0000
SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Investors of an Investigation Involving Possible Securities Fraud Violations by the Board of Directors of Pulse Biosciences, Inc.
Levi & Korsinsky announces it has commenced an investigation of Pulse Biosciences, Inc. concerning possible violations of federal securities laws.
Mon, 11 Sep 2017
18:20:00 +0000
Glancy Prongay & Murray LLP Commences Investigation on Behalf of Pulse Biosciences, Inc. Investors (PLSE)
Glancy Prongay & Murray LLP announces an investigation on behalf of Pulse Biosciences, Inc. investors concerning the Company and its officers’ possible violations of federal securities laws.
Mon, 11 Sep 2017
16:38:00 +0000
SHAREHOLDER ALERT: Bronstein, Gewirtz & Grossman, LLC Announces Investigation of Pulse Biosciences, Inc. (PLSE)
NEW YORK , Sept. 11, 2017 /PRNewswire/ -- Attorney Advertising--Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Pulse Biosciences, Inc.  ("Pulse" ...
Mon, 11 Sep 2017
15:17:00 +0000
EQUITY ALERT: Rosen Law Firm Announces Investigation of Securities Claims Against Pulse Biosciences, Inc.
Rosen Law Firm, a global investor rights law firm, announces it is investigating potential securities claims on behalf of shareholders of Pulse Biosciences, Inc. resulting from allegations that Pulse may have issued materially misleading business information to the investing public.
Mon, 11 Sep 2017
12:00:00 +0000
Pulse Biosciences Announces Withdrawal and Planned Resubmission of 510(k) Application for the PulseTxTM System
Pulse Biosciences, Inc. , a medical technology company developing a proprietary therapeutic tissue treatment based on its Nano-Pulse Stimulation platform, announced today that it has withdrawn its initial application to the United States Food and Drug Administration for 510 clearance of its PulseTxTM System.
Thu, 27 Jul 2017
20:00:00 +0000
Pulse Biosciences Quarterly Investor and Analyst Conference Call
Pulse Biosciences, Inc. , a medical technology company developing a proprietary therapeutic tissue treatment based on its Nano-Pulse Stimulation platform today reports recent corporate developments and financial results for the quarter ended June 30, 2017.
Thu, 27 Jul 2017
15:00:00 +0000
Investor Network: Pulse Biosciences, Inc. to Host Earnings Call
NEW YORK, NY / ACCESSWIRE / July 27, 2017 / Pulse Biosciences, Inc. (NASDAQ: PLSE ) will be discussing their earnings results in their Q2 Earnings Call to be held on Thursday, July 27, 2017 at 4:30 PM ...
Tue, 11 Jul 2017
23:30:00 +0000
Pulse Biosciences to Host Quarterly Investor Conference Call on July 27, 2017
Pulse Biosciences, Inc., a medical technology company developing a proprietary therapeutic tissue treatment platform based on Nano-Pulse Stimulation , will host its quarterly investor conference call on July 27, 2017, at 1:30 p.m.
Tue, 06 Jun 2017
12:00:00 +0000
Pulse Biosciences Announces Treatment of First Patient in Study to Evaluate the Safety and Efficacy of Novel Nano-Pulse Stimulation Technology for Seborrheic Keratosis Lesions
Pulse Biosciences, Inc. , a medical technology company developing a therapeutic tissue treatment platform based on its proprietary Nano-Pulse Stimulation technology, today announced treatment of the first patient in the Company’s multi-center study evaluating the safety and efficacy of the NPS technology for the treatment of seborrheic keratosis .



"ValueForum is an active, private, online discussion community for stock & bond market investing. In discussion forums divided into finely grained topics, you will find sophisticated investors trading tips, research, and due diligence on value stocks, income investments, forex, market news, and more. Join in - trade ideas, strategies, current news, via our unique message bulletin boards, stock ratings system, and other online tools specifically geared toward our community."

Random member testimonial: "This is a site for sharing information about the atypical investments that the majority of investors have not discovered. It is about finding the next value/growth sector/investment before all the major houses on the Street are recommending it." more testimonials »

Email / About | Privacy | Terms of Use | How To / FAQ | Msg Ticker | VF Home | My.vf | BDCs.vf | Energy.vf | REITs.vf | TA.vf
 
Nothing in ValueForum.com is intended to be investment advice, nor does it represent the opinion of, counsel
from, or recommendations by ValueForum.com. ©2003 - 2017, Powered in part by Ticker TechnologiesContact Us

Stock Market Investing Forum - Trading Tips & Research - Online Message Boards